Search

everythinglearnresearchcommunity

for

Search:↓

DHT stops hair regrowth in mice, similar to human hair loss.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Treatments for common hair loss include minoxidil, finasteride, and hair transplantation.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

Different skin cells process testosterone differently, and certain drugs can change this process, possibly helping treat acne and hair loss.

Finasteride and dutasteride reduce neurosteroid production, possibly helping treat glioblastoma.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Adrenal glands delay the start of winter fur growth in mink.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

New treatments for PCOS focus on managing symptoms and improving fertility.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

The skin acts like an endocrine organ, making hormones that affect skin diseases and respond to stress.

Young women with PCOS and no other heart risk factors have normal heart function.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

Current research explores hair growth drugs, while future research aims for personalized treatments.

Certain gene variations might be linked to severe acne in women but not in men.

The RORα gene is active in different parts of cashmere goat hair follicles and may be influenced by melatonin, especially in December when hair growth changes.